Ningjing Li

About

I am interested in GI oncology, immunotherapy, precision oncology.

Employment

• University of Cincinnati Experimental Therapeutic Fellow
  2022 - 2023

Education

• Dartmouth College PhD
  2008 - 2013
• Harbin Medical University MD
  2003 - 2008

Projects & Funding

Projects & funding information is unavailable.

Publications (24)

• Data from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
  2024 DOI: 10.1158/1078-0432.c.7234925.v1
  +Save
• Supplemental Table 7 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
  2024 DOI: 10.1158/1078-0432.25826606
  +Save
• Supplemental Table 7 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
  2024 DOI: 10.1158/1078-0432.25826606.v1
  +Save
• Supplemental Table 6 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
  2024 DOI: 10.1158/1078-0432.25826609.v1
  +Save
• Supplemental Table 6 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
  2024 DOI: 10.1158/1078-0432.25826609
  +Save
• Supplemental Table 5 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
  2024 DOI: 10.1158/1078-0432.25826612.v1
  +Save
• Supplemental Table 5 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
  2024 DOI: 10.1158/1078-0432.25826612
  +Save
• Supplemental Table 4 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
  2024 DOI: 10.1158/1078-0432.25826615.v1
  +Save
• Supplemental Table 4 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
  2024 DOI: 10.1158/1078-0432.25826615
  +Save
• Supplemental Table 3 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
  2024 DOI: 10.1158/1078-0432.25826618
  +Save